Diabetes May Be a Risk Factor for Stroke in Women With Gout
Assessment and management of comorbidities of gout can reduce future stroke risk in female patients.
All articles by Sheila Jacobs
Ultrasound-Measured Cortical Bone Porosity Linked to Nontraumatic Fracture in Postmenopausal Women
Cortical bidirectional axial transmission measurements may be useful for fracture risk assessment in postmenopausal women.
Comorbid Metabolic Syndrome, Psoriatic Arthritis Linked to Reduced Health-Related Quality of Life
Patients with plaque psoriasis have a reduced health-related quality of life, mainly in terms of emotional aspects.
Cardiovascular Comorbidity Screening Should Be Conducted in COPD With Obesity
Hypertension and diabetes are especially prevalent comorbidities in obese patients with chronic obstructive pulmonary disease.
Primary Hypertension May Not Affect Prognosis of Postmenopausal Osteoporosis
The presence of primary hypertension does not appear to have an effect on the prognosis of postmenopausal osteoporosis.
Topical Methyl Estradiolpropanoate Safe, Effective for Treating Estrogen-Deficient Skin
A study was conducted to assess the safety, tolerability, and efficacy of methyl estradiolpropanoate, a topical soft estrogen cosmeceutical for the treatment of estrogen-deficient skin.
COPD and Obesity: Is There a Dose-Response Relationship in Nonsmokers?
The odds of developing COPD were considerably higher in both men and women with class III obesity compared with normal weight individuals.
Risk for Type 2 Diabetes, Cardiovascular Disease Elevated in Patients With Psoriatic Arthritis
Risk for type 2 diabetes, ischemic heart disease, and peripheral vascular disease was elevated among patients with psoriatic arthritis compared with the general population.
Changes in Glucose Regulation in Parkinson Disease
Investigators sought to determine whether patients with moderate to advanced Parkinson disease have impaired glucose levels during an Oral Glucose Tolerance Test.
Real-World Data Show Reduced Fracture Rates in Teriparatide-Treated Osteoporosis
Rates of incident clinical vertebral fracture, incident nonvertebral fracture, hip fracture, and clinical fractures decreased 6 months after initiation of teriparatide.
Next post in Bone Metabolism
